tiprankstipranks
Trending News
More News >
Cyfuse Biomedical K.K. (JP:4892)
:4892
Japanese Market

Cyfuse Biomedical K.K. (4892) Financial Statements

Compare
0 Followers

Cyfuse Biomedical K.K. Financial Overview

Cyfuse Biomedical K.K.'s market cap is currently ¥6.80B. The company's EPS TTM is ¥-19.9; its P/E ratio is ―; Cyfuse Biomedical K.K. is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 54.45M¥ 61.11M¥ 374.48M¥ 708.25M¥ 137.48M
Gross Profit¥ 16.45M¥ 37.74M¥ 241.50M¥ 570.60M¥ 67.02M
Operating Income¥ -896.13M¥ -697.44M¥ -425.09M¥ 70.57M¥ -372.13M
EBITDA¥ -824.22M¥ -538.29M¥ -410.21M¥ 168.65M¥ -288.66M
Net Income¥ -872.24M¥ -589.21M¥ -473.96M¥ 142.91M¥ -329.50M
Balance Sheet
Cash & Short-Term Investments¥ 3.05B¥ 3.87B¥ 4.44B¥ 2.41B¥ 2.07B
Total Assets¥ 3.52B¥ 4.21B¥ 4.82B¥ 2.65B¥ 2.20B
Total Debt¥ 852.00M¥ 913.00M¥ 908.14M¥ 569.06M¥ 529.54M
Net Debt¥ -2.20B¥ -2.96B¥ -3.53B¥ -1.84B¥ -1.54B
Total Liabilities¥ 975.60M¥ 1.01B¥ 1.05B¥ 746.12M¥ 646.75M
Stockholders' Equity¥ 2.54B¥ 3.20B¥ 3.77B¥ 1.90B¥ 1.55B
Cash Flow
Free Cash Flow¥ -769.10M¥ -581.77M¥ -631.87M¥ 161.54M¥ -294.26M
Operating Cash Flow¥ -760.55M¥ -562.30M¥ -403.60M¥ 161.54M¥ -294.00M
Investing Cash Flow¥ -8.64M¥ -19.47M¥ -430.67M¥ -50.58M¥ -264.00K
Financing Cash Flow¥ -52.01M¥ 18.24M¥ 2.66B¥ 229.21M¥ 488.90M
Currency in JPY

Cyfuse Biomedical K.K. Earnings and Revenue History

Cyfuse Biomedical K.K. Debt to Assets

Cyfuse Biomedical K.K. Cash Flow

Cyfuse Biomedical K.K. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis